


A 2021 Update on Lupus Management & Treatment

FDA Approves Belimumab & Voclosporin for Lupus Nephritis
Monthly Belimumab Infusions Preserve Kidney Function in Some Lupus Patients

Lupus Treatments: Into the Future

Study Probes Whether Belimumab Can Lower Vasculitis Relapse Rate

In Wake of Lupus Trial Failure, New Research Attacks From Many Angles

Ixekizumab Promising for Non-Radiographic Axial SpA; Plus FDA Approves Belimumab for Pediatric Lupus

Treating Lupus: Strategies, Treat to Target & Biologics
